nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Tamoxifen—pancreatic cancer	0.0577	0.241	CbGbCtD
Bexarotene—CYP2C9—Fluorouracil—pancreatic cancer	0.0425	0.177	CbGbCtD
Bexarotene—CYP3A4—Tamoxifen—pancreatic cancer	0.0335	0.14	CbGbCtD
Bexarotene—CYP3A4—Erlotinib—pancreatic cancer	0.0285	0.119	CbGbCtD
Bexarotene—CYP3A4—Irinotecan—pancreatic cancer	0.0257	0.107	CbGbCtD
Bexarotene—CYP3A4—Docetaxel—pancreatic cancer	0.0189	0.0787	CbGbCtD
Bexarotene—CYP3A4—Sunitinib—pancreatic cancer	0.0188	0.0784	CbGbCtD
Bexarotene—CYP3A4—Doxorubicin—pancreatic cancer	0.0141	0.0587	CbGbCtD
Bexarotene—RXRG—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000988	0.00765	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000929	0.00719	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—PPARG—pancreatic cancer	0.00086	0.00666	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000856	0.00662	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—pancreatic cancer	0.000855	0.00662	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000845	0.00654	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.000839	0.00649	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—AHR—pancreatic cancer	0.000831	0.00643	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—CCND1—pancreatic cancer	0.000828	0.00641	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—MET—pancreatic cancer	0.000827	0.0064	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000805	0.00623	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—pancreatic cancer	0.000804	0.00622	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.000789	0.0061	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—HIF1A—pancreatic cancer	0.000772	0.00597	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—EGF—pancreatic cancer	0.00077	0.00596	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—HIF1A—pancreatic cancer	0.000753	0.00583	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—PIK3CA—pancreatic cancer	0.000742	0.00574	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—NFE2L2—pancreatic cancer	0.000738	0.00571	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—pancreatic cancer	0.000717	0.00555	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000717	0.00555	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.000707	0.00547	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFA—pancreatic cancer	0.000704	0.00545	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—pancreatic cancer	0.000698	0.0054	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC2A2—pancreatic cancer	0.000689	0.00533	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—pancreatic cancer	0.000687	0.00531	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00068	0.00526	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—MYC—pancreatic cancer	0.000664	0.00514	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.000663	0.00513	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—PPARG—pancreatic cancer	0.000656	0.00508	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—pancreatic cancer	0.000646	0.005	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—RB1—pancreatic cancer	0.000628	0.00486	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.000619	0.00479	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—GADD45A—pancreatic cancer	0.000616	0.00477	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—pancreatic cancer	0.000606	0.00469	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000595	0.00461	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000584	0.00452	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—pancreatic cancer	0.00057	0.00441	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CHD3—pancreatic cancer	0.000568	0.00439	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000567	0.00439	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000538	0.00416	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000534	0.00413	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—CHD3—pancreatic cancer	0.000534	0.00413	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000533	0.00413	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—HSPA1A—pancreatic cancer	0.00053	0.0041	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000527	0.00408	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000506	0.00391	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—pancreatic cancer	0.000489	0.00378	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.000484	0.00375	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR5A2—pancreatic cancer	0.000476	0.00368	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—CTNNB1—pancreatic cancer	0.000462	0.00358	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000461	0.00357	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000457	0.00354	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ACVR1B—pancreatic cancer	0.000456	0.00353	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NR5A2—pancreatic cancer	0.000456	0.00353	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000453	0.00351	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR5A2—pancreatic cancer	0.000447	0.00346	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00043	0.00333	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000419	0.00325	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—pancreatic cancer	0.000419	0.00324	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PDX1—pancreatic cancer	0.000412	0.00319	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.000411	0.00318	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—STAT3—pancreatic cancer	0.000403	0.00312	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000388	0.003	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—HIF1A—pancreatic cancer	0.000378	0.00293	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—pancreatic cancer	0.000373	0.00289	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—PPARG—pancreatic cancer	0.000368	0.00284	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—pancreatic cancer	0.000364	0.00281	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	0.00036	0.00278	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000351	0.00272	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000351	0.00272	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—pancreatic cancer	0.000349	0.0027	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000344	0.00267	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.00034	0.00263	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—pancreatic cancer	0.000336	0.0026	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NRP1—pancreatic cancer	0.000336	0.0026	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000334	0.00258	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000324	0.00251	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—PPARG—pancreatic cancer	0.000322	0.00249	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—RB1—pancreatic cancer	0.000308	0.00238	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—pancreatic cancer	0.000297	0.0023	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CHD3—pancreatic cancer	0.000278	0.00215	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—pancreatic cancer	0.000278	0.00215	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000278	0.00215	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MEN1—pancreatic cancer	0.000273	0.00211	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000264	0.00204	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SLC2A2—pancreatic cancer	0.00026	0.00201	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—pancreatic cancer	0.00026	0.00201	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NOTCH4—pancreatic cancer	0.000259	0.002	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MEN1—pancreatic cancer	0.000257	0.00199	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000254	0.00197	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000253	0.00196	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	0.000248	0.00192	CbGpPWpGaD
Bexarotene—Hypersensitivity—Irinotecan—pancreatic cancer	0.000248	0.000392	CcSEcCtD
Bexarotene—Pneumonia—Epirubicin—pancreatic cancer	0.000247	0.000392	CcSEcCtD
Bexarotene—RXRG—Gene Expression—HSPA1B—pancreatic cancer	0.000247	0.00191	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IAPP—pancreatic cancer	0.000247	0.00191	CbGpPWpGaD
Bexarotene—Hypertension—Docetaxel—pancreatic cancer	0.000246	0.000389	CcSEcCtD
Bexarotene—Bronchitis—Doxorubicin—pancreatic cancer	0.000245	0.000389	CcSEcCtD
Bexarotene—RXRB—Gene Expression—NOTCH4—pancreatic cancer	0.000243	0.00188	CbGpPWpGaD
Bexarotene—Arthralgia—Docetaxel—pancreatic cancer	0.000242	0.000384	CcSEcCtD
Bexarotene—Chest pain—Docetaxel—pancreatic cancer	0.000242	0.000384	CcSEcCtD
Bexarotene—Myalgia—Docetaxel—pancreatic cancer	0.000242	0.000384	CcSEcCtD
Bexarotene—Nausea—Sunitinib—pancreatic cancer	0.000242	0.000384	CcSEcCtD
Bexarotene—Pancytopenia—Doxorubicin—pancreatic cancer	0.000242	0.000384	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000242	0.00187	CbGpPWpGaD
Bexarotene—Asthenia—Irinotecan—pancreatic cancer	0.000241	0.000382	CcSEcCtD
Bexarotene—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000241	0.000382	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000241	0.000381	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—pancreatic cancer	0.00024	0.00185	CbGpPWpGaD
Bexarotene—Stomatitis—Epirubicin—pancreatic cancer	0.00024	0.00038	CcSEcCtD
Bexarotene—Jaundice—Epirubicin—pancreatic cancer	0.00024	0.00038	CcSEcCtD
Bexarotene—Conjunctivitis—Epirubicin—pancreatic cancer	0.000239	0.000378	CcSEcCtD
Bexarotene—Urinary tract infection—Epirubicin—pancreatic cancer	0.000239	0.000378	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000239	0.00185	CbGpPWpGaD
Bexarotene—Dysuria—Doxorubicin—pancreatic cancer	0.000238	0.000378	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—pancreatic cancer	0.000238	0.000378	CcSEcCtD
Bexarotene—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000237	0.000376	CcSEcCtD
Bexarotene—Dry mouth—Docetaxel—pancreatic cancer	0.000237	0.000376	CcSEcCtD
Bexarotene—Sweating—Epirubicin—pancreatic cancer	0.000236	0.000373	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—pancreatic cancer	0.000236	0.000373	CcSEcCtD
Bexarotene—Asthenia—Gemcitabine—pancreatic cancer	0.000235	0.000372	CcSEcCtD
Bexarotene—Haematuria—Epirubicin—pancreatic cancer	0.000234	0.000371	CcSEcCtD
Bexarotene—Confusional state—Docetaxel—pancreatic cancer	0.000234	0.000371	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NR5A2—pancreatic cancer	0.000233	0.0018	CbGpPWpGaD
Bexarotene—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000233	0.000369	CcSEcCtD
Bexarotene—Oedema—Docetaxel—pancreatic cancer	0.000232	0.000368	CcSEcCtD
Bexarotene—RXRB—Gene Expression—HSPA1B—pancreatic cancer	0.000232	0.0018	CbGpPWpGaD
Bexarotene—Weight increased—Doxorubicin—pancreatic cancer	0.000232	0.000368	CcSEcCtD
Bexarotene—Epistaxis—Epirubicin—pancreatic cancer	0.000232	0.000367	CcSEcCtD
Bexarotene—Pruritus—Gemcitabine—pancreatic cancer	0.000232	0.000367	CcSEcCtD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000232	0.00179	CbGpPWpGaD
Bexarotene—Infection—Docetaxel—pancreatic cancer	0.000231	0.000366	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—pancreatic cancer	0.000231	0.000366	CcSEcCtD
Bexarotene—Sinusitis—Epirubicin—pancreatic cancer	0.000231	0.000365	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00023	0.000364	CcSEcCtD
Bexarotene—Diarrhoea—Irinotecan—pancreatic cancer	0.00023	0.000364	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—pancreatic cancer	0.000229	0.000362	CcSEcCtD
Bexarotene—Shock—Docetaxel—pancreatic cancer	0.000229	0.000362	CcSEcCtD
Bexarotene—Nervous system disorder—Docetaxel—pancreatic cancer	0.000228	0.000361	CcSEcCtD
Bexarotene—Pruritus—Fluorouracil—pancreatic cancer	0.000228	0.000361	CcSEcCtD
Bexarotene—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000228	0.00036	CcSEcCtD
Bexarotene—Tachycardia—Docetaxel—pancreatic cancer	0.000227	0.000359	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—CTNNB1—pancreatic cancer	0.000226	0.00175	CbGpPWpGaD
Bexarotene—Skin disorder—Docetaxel—pancreatic cancer	0.000226	0.000358	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000225	0.00174	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—EZH2—pancreatic cancer	0.000225	0.00174	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000224	0.00173	CbGpPWpGaD
Bexarotene—Diarrhoea—Gemcitabine—pancreatic cancer	0.000224	0.000355	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000223	0.000353	CcSEcCtD
Bexarotene—Dizziness—Irinotecan—pancreatic cancer	0.000222	0.000352	CcSEcCtD
Bexarotene—Haemoglobin—Epirubicin—pancreatic cancer	0.000222	0.000351	CcSEcCtD
Bexarotene—Jaundice—Doxorubicin—pancreatic cancer	0.000222	0.000351	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—pancreatic cancer	0.000222	0.000351	CcSEcCtD
Bexarotene—Anorexia—Docetaxel—pancreatic cancer	0.000221	0.000351	CcSEcCtD
Bexarotene—Rhinitis—Epirubicin—pancreatic cancer	0.000221	0.00035	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000221	0.00035	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000221	0.00035	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000221	0.00171	CbGpPWpGaD
Bexarotene—Haemorrhage—Epirubicin—pancreatic cancer	0.000221	0.00035	CcSEcCtD
Bexarotene—Diarrhoea—Fluorouracil—pancreatic cancer	0.00022	0.000349	CcSEcCtD
Bexarotene—RXRG—Gene Expression—NOTCH3—pancreatic cancer	0.00022	0.0017	CbGpPWpGaD
Bexarotene—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000219	0.000348	CcSEcCtD
Bexarotene—Pharyngitis—Epirubicin—pancreatic cancer	0.000219	0.000347	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—pancreatic cancer	0.000218	0.000345	CcSEcCtD
Bexarotene—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000218	0.000345	CcSEcCtD
Bexarotene—Oedema peripheral—Epirubicin—pancreatic cancer	0.000217	0.000344	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—pancreatic cancer	0.000217	0.000344	CcSEcCtD
Bexarotene—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000217	0.000343	CcSEcCtD
Bexarotene—Urethral disorder—Epirubicin—pancreatic cancer	0.000216	0.000343	CcSEcCtD
Bexarotene—Epistaxis—Doxorubicin—pancreatic cancer	0.000214	0.00034	CcSEcCtD
Bexarotene—Vomiting—Irinotecan—pancreatic cancer	0.000214	0.000339	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—pancreatic cancer	0.000213	0.000338	CcSEcCtD
Bexarotene—Dizziness—Fluorouracil—pancreatic cancer	0.000213	0.000337	CcSEcCtD
Bexarotene—Rash—Irinotecan—pancreatic cancer	0.000212	0.000336	CcSEcCtD
Bexarotene—Dermatitis—Irinotecan—pancreatic cancer	0.000212	0.000336	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000212	0.000335	CcSEcCtD
Bexarotene—RXRB—Gene Expression—EZH2—pancreatic cancer	0.000212	0.00164	CbGpPWpGaD
Bexarotene—Headache—Irinotecan—pancreatic cancer	0.000211	0.000334	CcSEcCtD
Bexarotene—Insomnia—Docetaxel—pancreatic cancer	0.00021	0.000333	CcSEcCtD
Bexarotene—Paraesthesia—Docetaxel—pancreatic cancer	0.000209	0.000331	CcSEcCtD
Bexarotene—RXRG—Gene Expression—HSPA1A—pancreatic cancer	0.000209	0.00161	CbGpPWpGaD
Bexarotene—Vomiting—Gemcitabine—pancreatic cancer	0.000208	0.00033	CcSEcCtD
Bexarotene—Dyspnoea—Docetaxel—pancreatic cancer	0.000207	0.000328	CcSEcCtD
Bexarotene—RXRB—Gene Expression—NOTCH3—pancreatic cancer	0.000207	0.0016	CbGpPWpGaD
Bexarotene—Somnolence—Docetaxel—pancreatic cancer	0.000207	0.000327	CcSEcCtD
Bexarotene—Rash—Gemcitabine—pancreatic cancer	0.000206	0.000327	CcSEcCtD
Bexarotene—Dermatitis—Gemcitabine—pancreatic cancer	0.000206	0.000327	CcSEcCtD
Bexarotene—Eye disorder—Epirubicin—pancreatic cancer	0.000206	0.000327	CcSEcCtD
Bexarotene—Tinnitus—Epirubicin—pancreatic cancer	0.000206	0.000326	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—pancreatic cancer	0.000205	0.000325	CcSEcCtD
Bexarotene—Headache—Gemcitabine—pancreatic cancer	0.000205	0.000325	CcSEcCtD
Bexarotene—Cardiac disorder—Epirubicin—pancreatic cancer	0.000205	0.000324	CcSEcCtD
Bexarotene—Vomiting—Fluorouracil—pancreatic cancer	0.000205	0.000324	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—pancreatic cancer	0.000205	0.000324	CcSEcCtD
Bexarotene—Dyspepsia—Docetaxel—pancreatic cancer	0.000205	0.000324	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—pancreatic cancer	0.000204	0.000323	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000203	0.000322	CcSEcCtD
Bexarotene—Rash—Fluorouracil—pancreatic cancer	0.000203	0.000322	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000203	0.00157	CbGpPWpGaD
Bexarotene—Dermatitis—Fluorouracil—pancreatic cancer	0.000203	0.000321	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—pancreatic cancer	0.000203	0.000321	CcSEcCtD
Bexarotene—Decreased appetite—Docetaxel—pancreatic cancer	0.000202	0.00032	CcSEcCtD
Bexarotene—Headache—Fluorouracil—pancreatic cancer	0.000202	0.00032	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000202	0.000319	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000201	0.000319	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000201	0.000318	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000201	0.000318	CcSEcCtD
Bexarotene—Fatigue—Docetaxel—pancreatic cancer	0.0002	0.000317	CcSEcCtD
Bexarotene—Angiopathy—Epirubicin—pancreatic cancer	0.0002	0.000317	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—pancreatic cancer	0.0002	0.000317	CcSEcCtD
Bexarotene—Nausea—Irinotecan—pancreatic cancer	0.0002	0.000316	CcSEcCtD
Bexarotene—Pain—Docetaxel—pancreatic cancer	0.000199	0.000315	CcSEcCtD
Bexarotene—Constipation—Docetaxel—pancreatic cancer	0.000199	0.000315	CcSEcCtD
Bexarotene—Chills—Epirubicin—pancreatic cancer	0.000198	0.000314	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—STAT3—pancreatic cancer	0.000197	0.00153	CbGpPWpGaD
Bexarotene—Arrhythmia—Epirubicin—pancreatic cancer	0.000197	0.000312	CcSEcCtD
Bexarotene—RXRB—Gene Expression—HSPA1A—pancreatic cancer	0.000196	0.00152	CbGpPWpGaD
Bexarotene—Alopecia—Epirubicin—pancreatic cancer	0.000195	0.000309	CcSEcCtD
Bexarotene—Nausea—Gemcitabine—pancreatic cancer	0.000194	0.000308	CcSEcCtD
Bexarotene—Malnutrition—Epirubicin—pancreatic cancer	0.000192	0.000304	CcSEcCtD
Bexarotene—Erythema—Epirubicin—pancreatic cancer	0.000192	0.000304	CcSEcCtD
Bexarotene—Feeling abnormal—Docetaxel—pancreatic cancer	0.000191	0.000303	CcSEcCtD
Bexarotene—Nausea—Fluorouracil—pancreatic cancer	0.000191	0.000303	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—pancreatic cancer	0.000191	0.000302	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—pancreatic cancer	0.00019	0.000302	CcSEcCtD
Bexarotene—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00019	0.000301	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000189	0.0003	CcSEcCtD
Bexarotene—Flatulence—Epirubicin—pancreatic cancer	0.000189	0.0003	CcSEcCtD
Bexarotene—Tension—Epirubicin—pancreatic cancer	0.000188	0.000299	CcSEcCtD
Bexarotene—Dysgeusia—Epirubicin—pancreatic cancer	0.000188	0.000298	CcSEcCtD
Bexarotene—Nervousness—Epirubicin—pancreatic cancer	0.000187	0.000296	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000186	0.00144	CbGpPWpGaD
Bexarotene—Back pain—Epirubicin—pancreatic cancer	0.000186	0.000294	CcSEcCtD
Bexarotene—Angiopathy—Doxorubicin—pancreatic cancer	0.000185	0.000293	CcSEcCtD
Bexarotene—Muscle spasms—Epirubicin—pancreatic cancer	0.000185	0.000293	CcSEcCtD
Bexarotene—Abdominal pain—Docetaxel—pancreatic cancer	0.000184	0.000291	CcSEcCtD
Bexarotene—Body temperature increased—Docetaxel—pancreatic cancer	0.000184	0.000291	CcSEcCtD
Bexarotene—Chills—Doxorubicin—pancreatic cancer	0.000183	0.00029	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TGFB1—pancreatic cancer	0.000183	0.00142	CbGpPWpGaD
Bexarotene—Arrhythmia—Doxorubicin—pancreatic cancer	0.000182	0.000289	CcSEcCtD
Bexarotene—RXRA—Metabolism—PRSS1—pancreatic cancer	0.000181	0.0014	CbGpPWpGaD
Bexarotene—Alopecia—Doxorubicin—pancreatic cancer	0.00018	0.000286	CcSEcCtD
Bexarotene—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000178	0.000282	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—pancreatic cancer	0.000178	0.000282	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—pancreatic cancer	0.000178	0.000282	CcSEcCtD
Bexarotene—Anaemia—Epirubicin—pancreatic cancer	0.000177	0.000281	CcSEcCtD
Bexarotene—Agitation—Epirubicin—pancreatic cancer	0.000176	0.00028	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—pancreatic cancer	0.000175	0.000277	CcSEcCtD
Bexarotene—Tension—Doxorubicin—pancreatic cancer	0.000174	0.000276	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—pancreatic cancer	0.000174	0.000276	CcSEcCtD
Bexarotene—Malaise—Epirubicin—pancreatic cancer	0.000173	0.000274	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000173	0.00134	CbGpPWpGaD
Bexarotene—Nervousness—Doxorubicin—pancreatic cancer	0.000173	0.000273	CcSEcCtD
Bexarotene—Vertigo—Epirubicin—pancreatic cancer	0.000173	0.000273	CcSEcCtD
Bexarotene—Syncope—Epirubicin—pancreatic cancer	0.000172	0.000273	CcSEcCtD
Bexarotene—Leukopenia—Epirubicin—pancreatic cancer	0.000172	0.000272	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—pancreatic cancer	0.000172	0.000272	CcSEcCtD
Bexarotene—Hypersensitivity—Docetaxel—pancreatic cancer	0.000171	0.000271	CcSEcCtD
Bexarotene—Muscle spasms—Doxorubicin—pancreatic cancer	0.000171	0.000271	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—TNF—pancreatic cancer	0.000171	0.00132	CbGpPWpGaD
Bexarotene—Palpitations—Epirubicin—pancreatic cancer	0.00017	0.000269	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000169	0.00131	CbGpPWpGaD
Bexarotene—Loss of consciousness—Epirubicin—pancreatic cancer	0.000169	0.000267	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000168	0.0013	CbGpPWpGaD
Bexarotene—Cough—Epirubicin—pancreatic cancer	0.000168	0.000266	CcSEcCtD
Bexarotene—Asthenia—Docetaxel—pancreatic cancer	0.000167	0.000264	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—TGFB1—pancreatic cancer	0.000167	0.00129	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000166	0.00129	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SMAD4—pancreatic cancer	0.000166	0.00128	CbGpPWpGaD
Bexarotene—Hypertension—Epirubicin—pancreatic cancer	0.000166	0.000263	CcSEcCtD
Bexarotene—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000165	0.000261	CcSEcCtD
Bexarotene—Pruritus—Docetaxel—pancreatic cancer	0.000164	0.00026	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—pancreatic cancer	0.000164	0.00026	CcSEcCtD
Bexarotene—Myalgia—Epirubicin—pancreatic cancer	0.000163	0.000259	CcSEcCtD
Bexarotene—Arthralgia—Epirubicin—pancreatic cancer	0.000163	0.000259	CcSEcCtD
Bexarotene—Chest pain—Epirubicin—pancreatic cancer	0.000163	0.000259	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—pancreatic cancer	0.000163	0.000259	CcSEcCtD
Bexarotene—Anxiety—Epirubicin—pancreatic cancer	0.000163	0.000258	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000162	0.000257	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000162	0.00126	CbGpPWpGaD
Bexarotene—Discomfort—Epirubicin—pancreatic cancer	0.000162	0.000256	CcSEcCtD
Bexarotene—Malaise—Doxorubicin—pancreatic cancer	0.00016	0.000254	CcSEcCtD
Bexarotene—Dry mouth—Epirubicin—pancreatic cancer	0.00016	0.000253	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—pancreatic cancer	0.00016	0.000253	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—pancreatic cancer	0.000159	0.000252	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—pancreatic cancer	0.000159	0.000252	CcSEcCtD
Bexarotene—Diarrhoea—Docetaxel—pancreatic cancer	0.000159	0.000252	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—SMAD4—pancreatic cancer	0.000159	0.00123	CbGpPWpGaD
Bexarotene—Confusional state—Epirubicin—pancreatic cancer	0.000158	0.00025	CcSEcCtD
Bexarotene—RXRA—Metabolism—ARG2—pancreatic cancer	0.000157	0.00122	CbGpPWpGaD
Bexarotene—Palpitations—Doxorubicin—pancreatic cancer	0.000157	0.000249	CcSEcCtD
Bexarotene—Oedema—Epirubicin—pancreatic cancer	0.000157	0.000248	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000156	0.000247	CcSEcCtD
Bexarotene—RXRB—Gene Expression—SMAD4—pancreatic cancer	0.000156	0.00121	CbGpPWpGaD
Bexarotene—Infection—Epirubicin—pancreatic cancer	0.000156	0.000247	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—HES1—pancreatic cancer	0.000155	0.0012	CbGpPWpGaD
Bexarotene—Cough—Doxorubicin—pancreatic cancer	0.000155	0.000246	CcSEcCtD
Bexarotene—Shock—Epirubicin—pancreatic cancer	0.000154	0.000244	CcSEcCtD
Bexarotene—Nervous system disorder—Epirubicin—pancreatic cancer	0.000154	0.000244	CcSEcCtD
Bexarotene—Dizziness—Docetaxel—pancreatic cancer	0.000154	0.000243	CcSEcCtD
Bexarotene—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000153	0.000243	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—pancreatic cancer	0.000153	0.000243	CcSEcCtD
Bexarotene—Tachycardia—Epirubicin—pancreatic cancer	0.000153	0.000242	CcSEcCtD
Bexarotene—Skin disorder—Epirubicin—pancreatic cancer	0.000152	0.000241	CcSEcCtD
Bexarotene—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000152	0.00024	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—pancreatic cancer	0.000151	0.00024	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—pancreatic cancer	0.000151	0.00024	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—pancreatic cancer	0.000151	0.00024	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—pancreatic cancer	0.000151	0.000239	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.00015	0.00116	CbGpPWpGaD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00015	0.000238	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—pancreatic cancer	0.000149	0.000237	CcSEcCtD
Bexarotene—Anorexia—Epirubicin—pancreatic cancer	0.000149	0.000237	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—pancreatic cancer	0.000148	0.000234	CcSEcCtD
Bexarotene—Vomiting—Docetaxel—pancreatic cancer	0.000148	0.000234	CcSEcCtD
Bexarotene—Rash—Docetaxel—pancreatic cancer	0.000147	0.000232	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000146	0.00113	CbGpPWpGaD
Bexarotene—Dermatitis—Docetaxel—pancreatic cancer	0.000146	0.000232	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—pancreatic cancer	0.000146	0.000232	CcSEcCtD
Bexarotene—Headache—Docetaxel—pancreatic cancer	0.000146	0.000231	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—pancreatic cancer	0.000145	0.00023	CcSEcCtD
Bexarotene—Infection—Doxorubicin—pancreatic cancer	0.000144	0.000228	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000143	0.000226	CcSEcCtD
Bexarotene—Shock—Doxorubicin—pancreatic cancer	0.000143	0.000226	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000142	0.000225	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000142	0.000225	CcSEcCtD
Bexarotene—Insomnia—Epirubicin—pancreatic cancer	0.000142	0.000225	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—pancreatic cancer	0.000142	0.000224	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—pancreatic cancer	0.000141	0.000223	CcSEcCtD
Bexarotene—Paraesthesia—Epirubicin—pancreatic cancer	0.000141	0.000223	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00014	0.000222	CcSEcCtD
Bexarotene—Dyspnoea—Epirubicin—pancreatic cancer	0.00014	0.000221	CcSEcCtD
Bexarotene—Somnolence—Epirubicin—pancreatic cancer	0.000139	0.000221	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—pancreatic cancer	0.000138	0.000219	CcSEcCtD
Bexarotene—Nausea—Docetaxel—pancreatic cancer	0.000138	0.000219	CcSEcCtD
Bexarotene—Dyspepsia—Epirubicin—pancreatic cancer	0.000138	0.000219	CcSEcCtD
Bexarotene—RXRA—Metabolism—TYMP—pancreatic cancer	0.000137	0.00106	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—pancreatic cancer	0.000137	0.00106	CbGpPWpGaD
Bexarotene—Decreased appetite—Epirubicin—pancreatic cancer	0.000136	0.000216	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000135	0.000214	CcSEcCtD
Bexarotene—Fatigue—Epirubicin—pancreatic cancer	0.000135	0.000214	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000135	0.00104	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000134	0.00104	CbGpPWpGaD
Bexarotene—Pain—Epirubicin—pancreatic cancer	0.000134	0.000212	CcSEcCtD
Bexarotene—Constipation—Epirubicin—pancreatic cancer	0.000134	0.000212	CcSEcCtD
Bexarotene—RXRA—Gene Expression—MEN1—pancreatic cancer	0.000134	0.00104	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000132	0.000209	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000132	0.00102	CbGpPWpGaD
Bexarotene—Insomnia—Doxorubicin—pancreatic cancer	0.000131	0.000208	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—pancreatic cancer	0.00013	0.000206	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—pancreatic cancer	0.000129	0.000205	CcSEcCtD
Bexarotene—Feeling abnormal—Epirubicin—pancreatic cancer	0.000129	0.000205	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—pancreatic cancer	0.000129	0.000204	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000128	0.000994	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000128	0.000203	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—pancreatic cancer	0.000128	0.000202	CcSEcCtD
Bexarotene—RXRA—Gene Expression—NOTCH4—pancreatic cancer	0.000127	0.000982	CbGpPWpGaD
Bexarotene—Decreased appetite—Doxorubicin—pancreatic cancer	0.000126	0.0002	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000126	0.000972	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000125	0.000198	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—pancreatic cancer	0.000125	0.000198	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000125	0.000964	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000124	0.000963	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KDR—pancreatic cancer	0.000124	0.000962	CbGpPWpGaD
Bexarotene—Pain—Doxorubicin—pancreatic cancer	0.000124	0.000196	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—pancreatic cancer	0.000124	0.000196	CcSEcCtD
Bexarotene—Body temperature increased—Epirubicin—pancreatic cancer	0.000124	0.000196	CcSEcCtD
Bexarotene—Abdominal pain—Epirubicin—pancreatic cancer	0.000124	0.000196	CcSEcCtD
Bexarotene—RXRG—Gene Expression—NOTCH1—pancreatic cancer	0.000122	0.000946	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MET—pancreatic cancer	0.000122	0.000942	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPA1B—pancreatic cancer	0.000121	0.000937	CbGpPWpGaD
Bexarotene—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00012	0.000189	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000119	0.000188	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000117	0.000909	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NOTCH1—pancreatic cancer	0.000117	0.000906	CbGpPWpGaD
Bexarotene—Hypersensitivity—Epirubicin—pancreatic cancer	0.000115	0.000183	CcSEcCtD
Bexarotene—RXRG—Gene Expression—PPARG—pancreatic cancer	0.000115	0.000893	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NOTCH1—pancreatic cancer	0.000115	0.00089	CbGpPWpGaD
Bexarotene—Body temperature increased—Doxorubicin—pancreatic cancer	0.000115	0.000182	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—pancreatic cancer	0.000115	0.000182	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000114	0.000885	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000113	0.000877	CbGpPWpGaD
Bexarotene—Asthenia—Epirubicin—pancreatic cancer	0.000112	0.000178	CcSEcCtD
Bexarotene—Pruritus—Epirubicin—pancreatic cancer	0.000111	0.000176	CcSEcCtD
Bexarotene—RXRA—Metabolism—GLP1R—pancreatic cancer	0.000111	0.000857	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000111	0.000857	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—pancreatic cancer	0.000111	0.000855	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—EZH2—pancreatic cancer	0.00011	0.000853	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—DPYD—pancreatic cancer	0.000109	0.000843	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—pancreatic cancer	0.000108	0.00084	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NOTCH3—pancreatic cancer	0.000108	0.000835	CbGpPWpGaD
Bexarotene—Diarrhoea—Epirubicin—pancreatic cancer	0.000107	0.00017	CcSEcCtD
Bexarotene—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000107	0.000169	CcSEcCtD
Bexarotene—Asthenia—Doxorubicin—pancreatic cancer	0.000104	0.000165	CcSEcCtD
Bexarotene—Dizziness—Epirubicin—pancreatic cancer	0.000104	0.000164	CcSEcCtD
Bexarotene—RXRA—Metabolism—SLC2A2—pancreatic cancer	0.000103	0.0008	CbGpPWpGaD
Bexarotene—Pruritus—Doxorubicin—pancreatic cancer	0.000103	0.000163	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000102	0.000792	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HSPA1A—pancreatic cancer	0.000102	0.000791	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—pancreatic cancer	0.000101	0.000785	CbGpPWpGaD
Bexarotene—Vomiting—Epirubicin—pancreatic cancer	9.96e-05	0.000158	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—pancreatic cancer	9.92e-05	0.000157	CcSEcCtD
Bexarotene—Rash—Epirubicin—pancreatic cancer	9.88e-05	0.000157	CcSEcCtD
Bexarotene—Dermatitis—Epirubicin—pancreatic cancer	9.87e-05	0.000156	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.87e-05	0.000764	CbGpPWpGaD
Bexarotene—Headache—Epirubicin—pancreatic cancer	9.82e-05	0.000156	CcSEcCtD
Bexarotene—Dizziness—Doxorubicin—pancreatic cancer	9.59e-05	0.000152	CcSEcCtD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	9.35e-05	0.000723	CbGpPWpGaD
Bexarotene—Nausea—Epirubicin—pancreatic cancer	9.31e-05	0.000148	CcSEcCtD
Bexarotene—Vomiting—Doxorubicin—pancreatic cancer	9.22e-05	0.000146	CcSEcCtD
Bexarotene—Rash—Doxorubicin—pancreatic cancer	9.14e-05	0.000145	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—pancreatic cancer	9.14e-05	0.000145	CcSEcCtD
Bexarotene—Headache—Doxorubicin—pancreatic cancer	9.08e-05	0.000144	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.99e-05	0.000696	CbGpPWpGaD
Bexarotene—Nausea—Doxorubicin—pancreatic cancer	8.61e-05	0.000136	CcSEcCtD
Bexarotene—RXRA—Gene Expression—SMAD4—pancreatic cancer	8.13e-05	0.000629	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CD44—pancreatic cancer	8e-05	0.000619	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.84e-05	0.000607	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CTNNB1—pancreatic cancer	7.78e-05	0.000602	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.77e-05	0.000601	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GCG—pancreatic cancer	7.67e-05	0.000594	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—pancreatic cancer	7.63e-05	0.00059	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—STK11—pancreatic cancer	7.21e-05	0.000558	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—SRC—pancreatic cancer	7.03e-05	0.000544	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—pancreatic cancer	6.85e-05	0.00053	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—pancreatic cancer	6.78e-05	0.000525	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.77e-05	0.000524	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PRSS1—pancreatic cancer	6.77e-05	0.000524	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NRAS—pancreatic cancer	6.77e-05	0.000524	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—pancreatic cancer	6.7e-05	0.000518	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—pancreatic cancer	6.58e-05	0.000509	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—pancreatic cancer	6.29e-05	0.000487	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TYMS—pancreatic cancer	6.21e-05	0.00048	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—pancreatic cancer	6.19e-05	0.000479	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EGFR—pancreatic cancer	6.16e-05	0.000477	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NOTCH1—pancreatic cancer	5.99e-05	0.000464	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—pancreatic cancer	5.87e-05	0.000454	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ARG2—pancreatic cancer	5.87e-05	0.000454	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—pancreatic cancer	5.82e-05	0.000451	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—pancreatic cancer	5.65e-05	0.000438	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TYMP—pancreatic cancer	5.13e-05	0.000397	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—pancreatic cancer	5.05e-05	0.000391	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—pancreatic cancer	4.95e-05	0.000383	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.78e-05	0.00037	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—pancreatic cancer	4.56e-05	0.000353	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CG—pancreatic cancer	4.56e-05	0.000353	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.46e-05	0.000345	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—pancreatic cancer	4.4e-05	0.00034	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—pancreatic cancer	4.37e-05	0.000338	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—pancreatic cancer	4.29e-05	0.000332	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.23e-05	0.000327	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLP1R—pancreatic cancer	4.13e-05	0.00032	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—DPYD—pancreatic cancer	4.07e-05	0.000315	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CD—pancreatic cancer	4e-05	0.00031	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.87e-05	0.000299	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	3.86e-05	0.000299	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.82e-05	0.000296	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.69e-05	0.000285	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CB—pancreatic cancer	3.49e-05	0.00027	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—pancreatic cancer	3.46e-05	0.000268	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.38e-05	0.000262	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.36e-05	0.00026	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—pancreatic cancer	3.22e-05	0.000249	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—pancreatic cancer	3.02e-05	0.000233	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CD44—pancreatic cancer	2.99e-05	0.000231	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.93e-05	0.000226	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.9e-05	0.000224	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GCG—pancreatic cancer	2.86e-05	0.000222	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.73e-05	0.000211	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—STK11—pancreatic cancer	2.69e-05	0.000208	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.68e-05	0.000208	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.54e-05	0.000197	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.53e-05	0.000196	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.32e-05	0.000179	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—pancreatic cancer	2.24e-05	0.000173	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—pancreatic cancer	2.13e-05	0.000165	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CD44—pancreatic cancer	1.97e-05	0.000153	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GCG—pancreatic cancer	1.89e-05	0.000146	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—pancreatic cancer	1.88e-05	0.000146	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.78e-05	0.000138	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—STK11—pancreatic cancer	1.78e-05	0.000137	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—pancreatic cancer	1.74e-05	0.000135	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.7e-05	0.000132	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.64e-05	0.000127	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.53e-05	0.000118	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.5e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.3e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.29e-05	9.99e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—pancreatic cancer	1.24e-05	9.62e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.13e-05	8.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.12e-05	8.68e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.08e-05	8.38e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	9.86e-06	7.63e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.59e-06	6.65e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.52e-06	6.59e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	7.94e-06	6.15e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.43e-06	5.75e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—pancreatic cancer	6.49e-06	5.02e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.24e-06	4.05e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.28e-06	3.31e-05	CbGpPWpGaD
